AI assistant
Terns Pharmaceuticals, Inc. — Director's Dealing 2021
Feb 4, 2021
32559_dirs_2021-02-04_05673e0a-5f33-41d4-ac3b-cc3e02da7be4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2021-02-04
Reporting Person: Zhong Weidong (Director, Chief Scientific Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 285714 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.38 | 2028-07-10 | Common Stock (10714) | Direct | |
| Stock Option (Right to Buy) | $6.16 | 2029-01-10 | Common Stock (180714) | Direct | |
| Stock Option (Right to Buy) | $6.72 | 2030-03-15 | Common Stock (7142) | Direct | |
| Stock Option (Right to Buy) | $9.24 | 2030-12-29 | Common Stock (29236) | Direct |
Footnotes
F1: Reflects a 1-for-14 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.
F2: 1/48th of the shares subject to the option vest on each monthly anniversary measured from April 1, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F3: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 19, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F4: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 17, 2020 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F5: This option is early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from December 30, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.